June 9 (Reuters) - Xtek Ltd (XTE) Forecasting A$9 mln revenue in FY17 with high revenue growth and shift to profitability during 2H FY17
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025